FibroBiologics issues shares under $15M SEPA; converts $2.9M note principal

FibroBiologics, Inc.

Issued 118,991 shares as commitment fee at $2.1010/share on Jan 7, 2025.
Investor converted $900K, $500K, $500K, and $1.1M of Second Note between Jan 23 and Feb 7.
Conversion prices ranged $1.4955 to $1.6301; total shares issued: 1,936,628.
Second Note remaining principal is $2.0M as of Feb 7, 2025.
Sale relied on Section 4(a)(2) exemption; no public offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.